A share price of Cg Oncology Inc [CGON] is currently trading at $28.46, up 9.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The CGON shares have gain 4.98% over the last week, with a monthly amount glided 11.78%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, JP Morgan started tracking the stock with Overweight rating on May 02, 2025, and set its price target to $41. On April 16, 2025, Scotiabank initiated with a Sector Perform rating and assigned a price target of $23 on the stock. TD Cowen started tracking the stock assigning a Buy rating. UBS initiated its recommendation with a Buy and recommended $60 as its price target on October 24, 2024. RBC Capital Mkts started tracking with a Outperform rating for this stock on September 23, 2024, and assigned it a price target of $66. In a note dated August 28, 2024, ROTH MKM initiated an Buy rating and provided a target price of $65 on this stock.
Cg Oncology Inc experienced fluctuations in its stock price throughout the past year between $14.80 and $40.47. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $28.46 at the most recent close of the market. An investor can expect a potential return of 93.25% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Trailing Twelve Months sales for Cg Oncology Inc [NASDAQ:CGON] were 0.66M which represents -90.17% decline. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -203.02%, Pretax Profit Margin comes in at -159.45%, and Net Profit Margin reading is -159.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.17 and Total Capital is -0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cg Oncology Inc [NASDAQ:CGON] is 30.97. On the other hand, the Quick Ratio is 30.97, and the Cash Ratio is 1.83. Considering the valuation of this stock, the price to sales ratio is 3286.92, the price to book ratio is 3.08.
Transactions by insiders
Recent insider trading involved LEONARD E POST, Director, that happened on Jul 17 ’25 when 2000.0 shares were purchased. Director, POST LEONARD E completed a deal on May 21 ’25 to sell 1000.0 shares. Meanwhile, Director POST LEONARD E sold 1000.0 shares on Apr 28 ’25.
